The precision cancer business of PHC Holdings anticipates an increase in cancer cases and is expanding its digital pathology and immunohistochemistry instrument lineup.

Workers are ready to fight against real pay cuts, chronic staffing shortages and unsafe conditions, but their efforts are ...

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the launch of their first Laboratory Developed Test (LDT) FibroSIGHTtm ? now ...

Labor Dr. Wisplinghoff will offer GTC's next-generation sequencing-based tests for solid tumor and hematologic neoplasms.

Aiforia and Techcyte announce strategic collaboration to advance AI-powered digital pathology Aiforia Technologies Plc, Press Release, March 21, 2025 at 09:00 a.m. EET Aiforia, a trusted provider of d ...

Northwestern Medicine will be part of a multiyear, multicenter clinical trial to validate the performance and safety of the ...

Quest Diagnostics announced it is teaming up with Google Cloud to develop artificial intelligence programs that can personally respond to patients, providers and other customers. | That includes ...

The American College of Medical Genetics and Genomics (ACMG) welcomed six new directors, including a new president-elect, to its Board of Directors at the 2025 ACMG Annual Clinical Genetics Meeting in ...

Learn more about whether Charles River Laboratories International, Inc. or Stevanato Group S.p.A. is a better investment ...

Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression of symptoms in people with early-onset Alzheimer's.

Fulgent Genetics has a low Price/Book ratio and promising drug candidates. Key trial results are expected in May 2025. Read ...